Last week @fda sends out clarification on who can and cannot compound #glp1 like #tirzeaptide and #semaglutide and this week ProRx 503b shuts down GLP 1 compounding while @martymakary is photographed holding bootleg # FDA considers adding a dozen peptides to its bulk drug compounding list RAPS Alternative Treatments: Identifying Options After FDA Reclassification of Specific Peptides Bergen Total Health FDA Peptide Reclassification 2026: What Researchers Want